|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An investigation of the relationship between hepatoroxicity and the metabolism of N-alkyl-Formamides 显示文摘 | Kestell P | 1987 | Pharmacol Exp Ther1987，240，： | 1 |
| 2 | Increased plasma serotonin following treatment with flavone-8-acetic acid, DMXAA, vinblastine, and colchicine : relation to vascular effects显示文摘 | BAGULEY B C ZHUANG L KESTELL P | 1997 | Oncol Res1997，9，2： | 1 |
| 3 | Light-induced breakdown of flavoneacetic acid and xanthenone analogs in solution显示文摘 | Rewcastle G W Kestell P Baguley B | 1990 | Natl Cancer Inst1990，82，6： | 1 |
| 4 | An investigation of the re- lationship between the hepatotoxicity and the metabolism of N-alkylfor- mamides 显示文摘 | Kestell P Threadgill M D Gescher A | 1987 | J Pharmacol ExpTher1987，240，1： | 1 |
| 5 | Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-perform- ance liquid chromatography with ultraviolet detection 显示文摘 | Zhou S Li Y Kestell P | 2003 | J Chromatogr B Analyt Technol Biomed Life Sci2003，785，1： | 1 |
| 6 | Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells显示文摘 | Zhou S Feng X Kestell P | 2005 | Eur J Pharm Sci2005，24，： | 1 |
| 7 | Thalidomide in cancer treatment : a potential role in the elderly? 显示文摘 | Zhou S Kestell P Tingle MD | 2002 | Drugs Aging2002，19，2： | 1 |
| 8 | Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models:the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA),an anti-cancer drug eliminated mainly by conjugation显示文摘 | Zhou S Kestell P Paxton JW | 2002 | Drug Metab Rev2002，34，4： | 1 |
| 9 | Species differences in the metabolism of the antitumour agent 5,6 dimethylxanthenone 4 acetic acid in vitro :implications for prediction of metabolic interactions invivo显示文摘 | Zhou SF Tingle MD Kestell P | 2002 | Xenobiotica2002，32，2： | 1 |
| 10 | Preclinical factors influencing the relative contributions of Phase Ⅰ and Ⅱ enzymes to the metabolism of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acelic acid 显示文摘 | ZHOU S KESTELL P BAGULEY BC | 2003 | Biochem Pharmacol2003，65，1： | 1 |
| 11 | Light-induced breakdown of flavoneacetic acid and xanthenone analogs in solution 显示文摘 | Rewcastlee G W Kestell P Baguley B | 1990 | J Natl Cancer Inst1990，82，6： | 1 |
| 12 | Aninvestigation of the relationship between the hepatotoxicityand the metabolism of N-alkylformamides 显示文摘 | Kestell P Threadgill MD Gescher A | 1987 | JPharmacol Exp Ther1987，240，1： | 1 |
| 13 | Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5, 6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation显示文摘 | Zhou S Kestell P Paxton J W | 2002 | Drug Metab Rev2002，34，4： | 1 |
| 14 | The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-I knockout mice 显示文摘 | ZHAO L CHING LM KESTELL P | 2002 | Br J Cancer2002，87，4： | 1 |
| 15 | Ferguson Mechanisms by which resistant starches and non-starch poly-saccharide sources affect the metabolism and disposition of the food carcinogen, 2-amino-3 -methylimidazoquinoline显示文摘 | P Kestell S Zhu L R | 2004 | Journal of chromatography B2004，，802： | 1 |
| 16 | Plasma pharmacokinetics of N-acridine-4-carboxamide in a phase I trial 显示文摘 | Dunlop IC McCrystal MR | 1999 | Cancer Chemother Pharmacol1999，44，1： | 1 |
| 17 | Mechanisms by which re- sistant starches and non-starch polysaccharide sources affect the metabolism and disposition of the food carcinogen, 2-amino-3- methylimidazo quinoline 显示文摘 | KESTELL P ZHU S LERGUSON R F | 2004 | Journal of Chromatography B2004，802，： | 1 |
| 18 | Potentiation of theantitumour effect of cyclophosphamide in mice by thalidomide 显示文摘 | Ding Q Kestell P Baguley BC | 2002 | Cancer Chemother Pharmacol2002，50，3： | 1 |
| 19 | Gall-bladder sludge: lessons from ceftfiaxone显示文摘 | Kim Y S Kestell M F Lee S P | 1992 | J Gastroenterol Hepatol1992，7，6： | 1 |
| 20 | An investigation of the relationship between the hepatotoxicity and the metabolism of N-alkylformamides 显示文摘 | Kestell P Threadgill MD Gescher A | 1987 | J PharmacolExpTher1987，240，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员